H.U. Group Holdings, Inc. Stock price

Equities

4544

JP3822000000

Healthcare Facilities & Services

Delayed Japan Exchange 10:16:30 2024-03-18 pm EDT 5-day change 1st Jan Change
2,516 JPY -1.43% Intraday chart for H.U. Group Holdings, Inc. +0.10% -5.52%
Sales 2024 * 237B 1.59B Sales 2025 * 243B 1.63B Capitalization 145B 972M
Net income 2024 * 1.2B 8.02M Net income 2025 * 5.81B 38.98M EV / Sales 2024 * 0.77 x
Net Debt 2024 * 38.37B 257M Net Debt 2025 * 31.32B 210M EV / Sales 2025 * 0.72 x
P/E ratio 2024 *
122 x
P/E ratio 2025 *
25 x
Employees 5,437
Yield 2024 *
4.9%
Yield 2025 *
5.17%
Free-Float 98.83%
More Fundamentals * Assessed data
Dynamic Chart
H.U Unit Fujirebio Diagnostics Partners Beckman Coulter in Neurodegenerative Diseases Field MT
Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics CI
H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems CI
Japanese Shares Rebound After Inflation Data, BoJ Rate Outlook MT
H.U. Group to Issue Stock Options to Directors, Employees MT
H.U. Group to Grant Share Options to Staff MT
H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc.(TSE:4544) dropped from FTSE All-World Index CI
H.U. Group Holdings' Fiscal Full-Year Profit Falls 47% MT
H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2024 CI
H.U. Group Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023 CI
H.U. Group Holdings, Inc. Announces Launch of the Fully Automated Lumipulse® G NfL CSF and Lumipulse® G NfL Blood tests CI
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023 CI
H.U. Group Holdings, Inc. Provides Year End Dividend Forecast for the Fiscal Year Ending March 31, 2023 CI
More news
1 day-0.86%
1 week-0.47%
Current month-1.52%
1 month-7.95%
3 months-2.52%
6 months-4.13%
Current year-4.97%
More quotes
1 week
2 453.00
Extreme 2453
2 561.50
1 month
2 453.00
Extreme 2453
2 759.00
Current year
2 453.00
Extreme 2453
2 841.50
1 year
2 404.00
Extreme 2404
2 863.00
3 years
2 404.00
Extreme 2404
3 770.00
5 years
2 005.00
Extreme 2005
3 770.00
10 years
2 005.00
Extreme 2005
6 350.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 16-05-31
Director of Finance/CFO 65 20-06-30
Chief Tech/Sci/R&D Officer 68 21-06-22
Members of the board TitleAgeSince
Chief Executive Officer 70 16-05-31
Director/Board Member 53 11-08-31
Director/Board Member 76 18-05-31
More insiders
Date Price Change Volume
24-03-18 2,516 -1.43% 144 600
24-03-18 2,553 +0.49% 358,200
24-03-15 2,540 +0.91% 432,500
24-03-14 2,518 +1.92% 306,200
24-03-13 2,470 -1.75% 534,200

Delayed Quote Japan Exchange, March 18, 2024 at 08:08 pm EDT

More quotes
H.U. Group Holdings Inc, formerly Miraca Holdings Inc is a Japan-based holding company engaged in manufacture and sale of clinical test drugs, entrusted clinical examination and sterilization related business. The Company operates in four business segments. The Outsourced Clinical Testing segment accepts special tests from medical institutions. The Clinical Laboratory Medicine segment manufactures and sells clinical laboratory medicines and sells them to medical institutions and contract clinical laboratory companies. The Sterilization segment mainly entrusts the sterilization of medical equipment used for medical treatment in hospitals of large-scale hospitals and the related operations. The New Development & Others segment is involved in the homecare & welfare equipment business, self-medication & health insurance business, food & environment & cosmetics inspection business.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
5
Last Close Price
2,553 JPY
Average target price
2,602 JPY
Spread / Average Target
+1.92%
Consensus
  1. Stock
  2. Equities
  3. Stock H.U. Group Holdings, Inc. - Japan Exchange